HUT73528A - 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use - Google Patents

4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use

Info

Publication number
HUT73528A
HUT73528A HU9500694A HU9500694A HUT73528A HU T73528 A HUT73528 A HU T73528A HU 9500694 A HU9500694 A HU 9500694A HU 9500694 A HU9500694 A HU 9500694A HU T73528 A HUT73528 A HU T73528A
Authority
HU
Hungary
Prior art keywords
me2c
hydrogen
azetidine
oxo
salts
Prior art date
Application number
HU9500694A
Other languages
English (en)
Other versions
HU217979B (hu
HU9500694D0 (en
Inventor
Zinka Brkic
Jure J Herak
Mice Kovacevic
Irena Lukic
Zora Mandic
Mirjana Tomic
Original Assignee
Pliva Pharm & Chem Works
Pliva Handels Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Pharm & Chem Works, Pliva Handels Gmbh filed Critical Pliva Pharm & Chem Works
Publication of HU9500694D0 publication Critical patent/HU9500694D0/hu
Publication of HUT73528A publication Critical patent/HUT73528A/hu
Publication of HU217979B publication Critical patent/HU217979B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
HU9500694A 1992-09-08 1993-09-08 Eljárás 4-oxo-azetidin-2-szulfonsav-amidok és sóik, valamint ezeket tartalmazó gyógyászati készítmények előállítására HU217979B (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4230053A DE4230053A1 (de) 1992-09-08 1992-09-08 4-Oxo-azetidin-2-sulfonsäureamide und ihre Salze, Verfahren zu deren Herstellung und ihre Verwendung

Publications (3)

Publication Number Publication Date
HU9500694D0 HU9500694D0 (en) 1995-04-28
HUT73528A true HUT73528A (en) 1996-08-28
HU217979B HU217979B (hu) 2000-05-28

Family

ID=6467533

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9500694A HU217979B (hu) 1992-09-08 1993-09-08 Eljárás 4-oxo-azetidin-2-szulfonsav-amidok és sóik, valamint ezeket tartalmazó gyógyászati készítmények előállítására

Country Status (19)

Country Link
US (1) US5466686A (hu)
EP (1) EP0659177B1 (hu)
JP (1) JPH08501093A (hu)
CN (1) CN1042130C (hu)
AT (1) ATE187441T1 (hu)
BG (1) BG62135B1 (hu)
CA (1) CA2142275A1 (hu)
CZ (1) CZ54595A3 (hu)
DE (2) DE4230053A1 (hu)
ES (1) ES2142350T3 (hu)
GR (1) GR3032702T3 (hu)
HR (1) HRP930613A2 (hu)
HU (1) HU217979B (hu)
PL (1) PL173895B1 (hu)
PT (1) PT659177E (hu)
RO (1) RO115256B1 (hu)
RU (1) RU2124003C1 (hu)
SK (1) SK29295A3 (hu)
WO (1) WO1994005632A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP921292A2 (en) * 1992-11-17 1994-08-31 Pliva Pharm & Chem Works 5-thia-1,4-diazabicyclo (4.2.0.)octane -3,8-dioxo analogs of beta-lactams, the process for the preparation and use thereof
HRP970146A2 (en) * 1997-03-13 1998-10-31 Mice Kovacevic Epoxi-azetidines, preparation and use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1056372A (en) * 1974-12-24 1979-06-12 Eli Lilly And Company Method of preparation of 3-methylenecephams
JPS58210060A (ja) * 1982-05-31 1983-12-07 Takeda Chem Ind Ltd 2−オキソアゼチジン誘導体、その製造法および用途
US4436596A (en) * 1982-11-16 1984-03-13 Eli Lilly And Company N-Substituted-2-(R)-(sulfinic acid)-3-(S)-(acylamido)-4-oxo-azetidines and process
RU2043988C1 (ru) * 1991-02-12 1995-09-20 Плива Хандельс ГмбХ 4-оксоазетидин-2-сульфоновые кислоты или их соли в качестве промежуточных продуктов в синтезе бета-лактамовых антибиотиков и способ их получения

Also Published As

Publication number Publication date
CZ54595A3 (en) 1995-12-13
ES2142350T3 (es) 2000-04-16
PT659177E (pt) 2000-04-28
BG99296A (bg) 1995-12-29
DE4230053A1 (de) 1994-03-10
EP0659177B1 (de) 1999-12-08
EP0659177A1 (de) 1995-06-28
HRP930613A2 (en) 1998-06-30
HU217979B (hu) 2000-05-28
RU2124003C1 (ru) 1998-12-27
PL307851A1 (en) 1995-06-26
RU95111375A (ru) 1997-03-20
ATE187441T1 (de) 1999-12-15
WO1994005632A1 (de) 1994-03-17
CN1099750A (zh) 1995-03-08
DE59309898D1 (de) 2000-01-13
BG62135B1 (bg) 1999-03-31
CA2142275A1 (en) 1994-03-17
US5466686A (en) 1995-11-14
PL173895B1 (pl) 1998-05-29
GR3032702T3 (en) 2000-06-30
JPH08501093A (ja) 1996-02-06
CN1042130C (zh) 1999-02-17
SK29295A3 (en) 1995-09-13
HU9500694D0 (en) 1995-04-28
RO115256B1 (ro) 1999-12-30

Similar Documents

Publication Publication Date Title
MY102866A (en) Amide derivatives.
GR3029775T3 (en) Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them
TW274547B (hu)
FI943948A (fi) Heterosykliset hiilihappojohdannaiset
ES8609303A1 (es) Un procedimiento para la preparacion de un derivado de acido6-fluor-1,4-dihidro-4-oxo-7-piperazinilquinolin sustituido-3-carboxilico
HUT48589A (en) Process for production of new derivatives of substituated n-/1-hydroxi-4-piperidinil/-benzamid
AU1400801A (en) Aralkyl-1,2-diamines having calcimimetic activity and preparation mode
DE3873578D1 (de) Verwendung von tetrahydrobenz(c,d)indol-6-carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
HUP0104033A2 (hu) Benzoilpiridazin-származékok, a vegyületeket tartalmazó gyógyszerkészítmények, eljárás az előállításukra és alkalmazásuk
HUP0003577A2 (hu) Tetrahidro-gamma-karbolinok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
ES8605507A1 (es) Un compuesto de 3-indolcarboxamida
ES8606880A1 (es) Un procedimiento para la preparacion de nuevos peptidos.
HUT73528A (en) 4-oxo-azetidine-2-sulphonic acid amides and their salts, process for their production and their use
IL117980A (en) Triazolone derivatives their preparation and pharmaceutical compositions containing them useful for the treatment of hyperlipidemia
ATE169635T1 (de) Therapeutische verbindungen für die behandlung von krankheiten, die mit einem glutathion-defizit assoziiert sind, herstellungsprozess und diese enthaltene pharmazeutische zusammensetzungen
SG82540A1 (en) N-substituted azabicyclo [3.2.0] heptane derivatives as neuroleptics, the preparation and use thereof
ATE90673T1 (de) Antifolat-mittel.
IL113254A (en) Substituted azolone derivatives their preparation and pharmaceutical compositions containing them
DE3674546D1 (de) Amidderivate.
ES8304125A1 (es) "un procedimiento para la preparacion de nuevos derivados de oxodiazolopirimidina".
IL99777A0 (en) Indole derivatives,processes for their preparation and pharmaceutical compositions containing them
ES478502A1 (es) Un procedimiento para la preparacion de nuevas n-(piridotie-nopirazol)amidas
SU1781999A1 (ru) Ртутная соль адамантан-1-карбоновой кислоты, проявляющая антисептическую активность

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee